Key result
Proteogenomics profiling of ARVC hearts revealed lipid metabolism reprogramming driven by C/EBPα activation and upregulation of lipogenesis targets compared to DCM and normal hearts.
Population
Explanted human hearts: 4 ARVC, 4 DCM, and normal hearts for proteomics; 10 ARVC right ventricles and 4…
Comparison
Comprehensive myocardial proteogenomics profiling vs DCM explanted hearts and nondiseased donor hearts
Design
Preclinical
Authors
Loading...
TMT proteomics of ARVC myocardium extends limited prior profiling; hypothesis-generating for biomarkers and mechanisms.
Observational
Comprehensive proteogenomic profiling identifies C/EBPα-driven lipid metabolism reprogramming as a hallmark of ARVC, providing potential new molecular targets.
Chen et al. (2017) conducted an observational in Arrhythmogenic right ventricular cardiomyopathy (ARVC). Arrhythmogenic right ventricular cardiomyopathy (ARVC) vs. Dilated cardiomyopathy (DCM) and normal hearts was evaluated on Proteome and transcriptome patterns. Proteogenomics profiling of ARVC hearts revealed lipid metabolism reprogramming driven by C/EBPα activation and upregulation of lipogenesis targets compared to DCM and normal hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: